Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.09B |
| 2 |
Apple
AAPL
|
+$871M |
| 3 |
Uber
UBER
|
+$867M |
| 4 |
NVIDIA
NVDA
|
+$687M |
| 5 |
Amazon
AMZN
|
+$649M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$1.52B |
| 2 |
Danaher
DHR
|
+$540M |
| 3 |
VMW
VMware, Inc
VMW
|
+$474M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$450M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$388M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.83% |
| 2 | Financials | 12.77% |
| 3 | Healthcare | 12.47% |
| 4 | Consumer Discretionary | 11% |
| 5 | Industrials | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRUS
3201
DELISTED
Merus
MRUS
| $1.47M | ﹤0.01% |
53,608
+150
| +0.3% | +$3.5K |
|
3202
Natural Gas Services Group
NGS
$479M
| $1.47M | ﹤0.01% |
91,302
+3,142
| +4% | +$45.4K |
|
3203
Inovio Pharmaceuticals
INO
$69.8M
| $1.46M | ﹤0.01% |
239,287
+10,035
| +4% | +$49.5K |
|
3204
Aclaris Therapeutics
ACRS
$818M
| $1.46M | ﹤0.01% |
1,393,548
+56,466
| +4% | +$172K |
|
3205
AbCellera Biologics
ABCL
$1.85B
| $1.46M | ﹤0.01% |
256,144
+846
| +0.3% | +$3.92K |
|
|
LENZ
3206
LENZ Therapeutics
LENZ
$157M
| $1.45M | ﹤0.01% |
79,308
+2,509
| +3% | +$41.4K |
|
3207
Equinor
EQNR
$92.6B
| $1.45M | ﹤0.01% |
45,714
| – | – |
|
3208
PrimeEnergy Resources
PNRG
$301M
| $1.45M | ﹤0.01% |
13,592
+61
| +0.5% | +$6.51K |
|
|
OMGA
3209
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $1.44M | ﹤0.01% |
477,638
+19,056
| +4% | +$38.6K |
|
3210
Orion Group Holdings
ORN
$411M
| $1.43M | ﹤0.01% |
290,412
+9,611
| +3% | +$47.3K |
|
|
ALIM
3211
DELISTED
Alimera Sciences
ALIM
| $1.43M | ﹤0.01% |
331,977
+279,153
| +528% | +$943K |
|
3212
PepGen
PEPG
$131M
| $1.43M | ﹤0.01% |
210,053
+10,776
| +5% | +$59.1K |
|
3213
First Northwest Bancorp
FNWB
$108M
| $1.43M | ﹤0.01% |
89,582
+2,207
| +3% | +$30.8K |
|
3214
VistaGen Therapeutics
VTGN
$12.2M
| $1.41M | ﹤0.01% |
274,472
+201,308
| +275% | +$762K |
|
|
GTHX
3215
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $1.41M | ﹤0.01% |
460,775
+20,142
| +5% | +$37.8K |
|
3216
Acme United Corp
ACU
$215M
| $1.4M | ﹤0.01% |
32,750
+311
| +1% | +$10.9K |
|
3217
Hurco Companies Inc
HURC
$139M
| $1.4M | ﹤0.01% |
65,192
+3,212
| +5% | +$66.8K |
|
|
DFTX
3218
Definium Therapeutics
DFTX
$5.67B
| $1.38M | ﹤0.01% |
377,915
+6,602
| +2% | +$19.9K |
|
3219
Peoples Bancorp of North Carolina
PEBK
$233M
| $1.38M | ﹤0.01% |
45,794
+1,367
| +3% | +$34.4K |
|
|
GHLD
3220
DELISTED
Guild Holdings
GHLD
| $1.38M | ﹤0.01% |
97,643
+3,049
| +3% | +$36.9K |
|
|
SWKH
3221
DELISTED
SWK Holdings
SWKH
| $1.37M | ﹤0.01% |
98,808
-225
| -0.2% | -$2.94K |
|
3222
Ambev
ABEV
$47.1B
| $1.37M | ﹤0.01% |
489,215
-3,938
| -0.8% | -$10.6K |
|
|
AEVA
3223
Aeva Technologies
AEVA
$1.37B
| $1.37M | ﹤0.01% |
360,722
+15,234
| +4% | +$48.7K |
|
3224
Bassett Furniture
BSET
$170M
| $1.36M | ﹤0.01% |
82,177
+975
| +1% | +$15.5K |
|
3225
Upland Software
UPLD
$12.9M
| $1.36M | ﹤0.01% |
32,064
+1,198
| +4% | +$51.8K |
|
Similar funds
Geode Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, Geode Capital Management held 4,831 positions worth $956B, up 14% from $840B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Geode Capital Management's Q4 2023 filing shows 71 new, 3,576 increased, 304 reduced and 178 closed positions. Its largest new stake was NCR Atleos: 993,462 shares worth $24.2M. The largest sale was Activision Blizzard, an estimated $1.52B.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q4 2023 buy was NCR Atleos: 993,462 shares worth $24.2M.
- Geode Capital Management added most to Microsoft in Q4 2023, an estimated $1.09B increase.
- Geode Capital Management's biggest Q4 2023 reduction was Danaher, cutting an estimated $540M.
- Geode Capital Management fully exited Activision Blizzard in Q4 2023, selling an estimated $1.52B.
- Geode Capital Management's ten largest holdings make up 26% of its $956B portfolio in Q4 2023.
- Geode Capital Management opened 71 new positions and closed 178 in Q4 2023.
- Geode Capital Management's portfolio value rose 14% quarter-over-quarter to $956B.
Based on Geode Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.